Ginwa Enterprise (Group) Inc. (SHA:600080)
4.910
-0.070 (-1.41%)
Sep 10, 2026, 3:00 PM CST
Ginwa Enterprise (Group) Revenue
Ginwa Enterprise (Group) had revenue of 118.71M CNY in the quarter ending June 30, 2026, a decrease of -11.39%. This brings the company's revenue in the last twelve months to 548.40M, down -5.58% year-over-year. In the year 2025, Ginwa Enterprise (Group) had annual revenue of 544.04M, down -7.07%.
Revenue (ttm)
548.40M
Revenue Growth
-5.58%
P/S Ratio
3.19
Revenue / Employee
894.62K
Employees
613
Market Cap
1.75B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 544.04M | -41.42M | -7.07% |
| Dec 31, 2024 | 585.46M | 20.06M | 3.55% |
| Dec 31, 2023 | 565.40M | -13.97M | -2.41% |
| Dec 31, 2022 | 579.37M | 45.34M | 8.49% |
| Dec 31, 2021 | 534.04M | -134.14M | -20.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.67M |
| Zhejiang Shengda Bio-Pharm | 832.86M |
| Enwei Pharmaceutical | 826.13M |
| Hainan Huluwa Pharmaceutical Group | 634.04M |
| Zhejiang Shapuaisi Pharmaceutical | 423.20M |
| Anhui Huangshan Capsule | 407.10M |
| Guhan Pharmaceutical Group | 329.41M |
| Qinghai Spring Medicinal Resources Technology | 303.67M |